FIBROGEN INC·4

Sep 8, 4:59 PM ET

Eisner Mark 4

4 · FIBROGEN INC · Filed Sep 8, 2023

Insider Transaction Report

Form 4
Period: 2023-09-06
Eisner Mark
Incoming Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-09-06$0.96/sh1,860$1,791159,917 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION